Stress-Regulated Transcription Factor ATF4 Promotes Neoplastic Transformation by Suppressing Expression of the INK4a/ARF Cell Senescence Factors
Published version of a preprint
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Many cancers overexpress ATF4, a stress-induced transcription factor that promotes cell survival under hypoxic conditions and other stresses of the tumor microenvironment, but the potential contributions of ATF4 to oncogenesis itself have been little explored. Here, we report that ATF4 promotes oncogene-induced neoplastic transformation by suppressing the expression of cellular senescence-associated genes. Strikingly, primary embryo fibroblasts from ATF4-deficient mice were resistant to transformation by coexpression of H-rasV12 and SV40 large T antigen. In wild-type cells these oncogenes induced expression of the murine Atf4 gene along with the cyclin-dependent kinase inhibitor Cdkn2a, which encodes the cell senescence-associated proteins p16INK4 and p19ARF. Elevated levels of ATF4 were sufficient to suppress expression of these proteins and drive oncogenic transformation. Conversely, genetic ablation of ATF4 led to constitutive expression of p16INK4a and p19ARF, triggering cellular senescence. Our findings define a central function for ATF4 in promoting oncogenic transformation by suppressing a central pathway of cellular senescence. Cancer Res; 72(2); 395–401. ©2011 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482 · cited 1×
“In contrast to reversible cell cycle arrest, cellular senescence is defined by irreversible loss of proliferative potential, acquisition of characteristic morphology, and expression of specific biomarkers, such as SA β-gal (8,17).”
BackgroundSenescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 3×
“In contrast to reversible cell cycle arrest, cellular senescence is defined by irreversible loss of proliferative potential, acquisition of characteristic morphology, and expression of specific biomarkers, such as SA β-gal (8,17).”
BackgroundThe Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009 · cited 3×
“progression: the induction of these proteins is critical for causing cellular senescence (8,9).”
BackgroundINK4a/ARF: A multifunctional tumor suppressor locus
Sharpless, N. E. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.08.021 · Cited by 442
Research works printed but not linked: 14
- Ameri, 2008, Activating transcription factor 4, Int J Biochem Cell Biol, 40, 14, 10.1016/j.biocel.2007.01.020 · DOI · Paper page
- Ye, 2010, The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation, EMBO J, 29, 2082, 10.1038/emboj.2010.81 · DOI · Paper page
- Bi, 2005, ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth, EMBO J, 24, 3470, 10.1038/sj.emboj.7600777 · DOI · Paper page
- Kakumoto, 2006, FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts, PNAS, 103, 5490, 10.1073/pnas.0601222103 · DOI
- Okazaki, 2010, Circadian rhythm of transferrin receptor 1 gene expression controlled by c-Myc in colon cancer-bearing mice, Cancer Res, 70, 6238, 10.1158/0008-5472.CAN-10-0184 · DOI
- Horiguchi, 2010, Glucocorticoid-dependent expression of O(6)-methylguanine-DNA methyltransferase gene modulates dacarbazine-induced hepatotoxicity in mice, J Pharmacol Exp Ther, 333, 782, 10.1124/jpet.110.165597 · DOI
- Kanehisa, 2002, The KEGG databases at GenomeNet, Nucleic Acids Res, 30, 42, 10.1093/nar/30.1.42 · DOI · Paper page
- Sherr, 2006, Divorcing ARF and p53: an unsettled case, Nat Rev Cancer, 6, 663, 10.1038/nrc1954 · DOI · Paper page
- Gachon, 2001, The cAMP response element binding protein-2 (CREB-2) can interact with the C/EBP-homologous protein (CHOP), FEBS Lett, 502, 57, 10.1016/S0014-5793(01)02646-1 · DOI
- Kato, 1999, Presence of activating transcription factor 4 (ATF4) in the porcine anterior pituitary, Mol Cell Endocrinol, 154, 151, 10.1016/S0303-7207(99)00078-7 · doi:10.1016/s0303-7207(99)00078-7
- Kilberg, 2009, ATF4-dependent transcription mediates signaling of amino acid limitation, Trends Endocrinol Metab, 20, 436, 10.1016/j.tem.2009.05.008 · DOI · Paper page
- Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
- Zhu, 1991, The ability of simian virus 40 large T antigen to immortalize primary mouse embryo fibroblasts cosegregates with its ability to bind to p53, J Virol, 65, 6872, 10.1128/jvi.65.12.6872-6880.1991 · DOI
- Ewen, 1989, An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120, Cell, 58, 257, 10.1016/0092-8674(89)90840-4 · DOI · Paper page
Cited by
Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine
Zhang, J., Pavlova, N. N., & Thompson, C. B. (2017) · The EMBO Journal · doi:10.15252/embj.201696151 · Cited by 651
Asparagine Plays a Critical Role in Regulating Cellular Adaptation to Glutamine Depletion
Zhang, J., Fan, J., Venneti, S., Cross, J. R., Takagi, T., Bhinder, B., Djaballah, H., Kanai, M., Cheng, E. H., Judkins, A. R., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.018 · Cited by 439
“The activation of the GCN2/eIF2a/ATF4 pathway has been reported in primary solid tumors, and GCN2- or ATF4-deficient cells failed to give rise to tumors in vivo (Horiguchi et al., 2012; Ye et al., 2010), suggesting that to maintain asparagine production is critical for solid tumor progression in their nutrient-limited…”
BackgroundOxidative stress in apoptosis and cancer: an update
Matés, J. M., Segura, J. A., Alonso, F. J., & Márquez, J. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0906-3 · Cited by 341
Pluquet, O., Pourtier, A., & Abbadie, C. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00334.2014 · Cited by 305
“Primary embryo fibroblasts HRas and SV40 large T antigen ATF4 / Triggered senescence by expressing constitutively p16INK4 and p19ARF (53)”
BackgroundTumor Microenvironment in Head and Neck Squamous Cell Carcinoma
Curry, J. M., Sprandio, J., Cognetti, D., Luginbuhl, A., Bar-ad, V., Pribitkin, E., & Tuluc, M. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.03.003 · Cited by 293
Metadata
- Authors
- Horiguchi, M., Koyanagi, S., Okamoto, A., Suzuki, S. O., Matsunaga, N., & Ohdo, S.
- Venue
- Cancer Research
- Published
- 2012-01-15
- Volume
- 72
- Issue
- 2
- Pages
- 395-401
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2160644663
- Cited by
- 58
- References
- 5
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stress-Regulated Transcription Factor ATF4 Promotes Neoplastic Transformation by Suppressing Expression of the INK4a/ARF Cell Senescence Factors. https://app.cochat.ai/papers/10.1158/0008-5472.can-11-1891
- The paper
- Horiguchi, M., Koyanagi, S., Okamoto, A., Suzuki, S. O., Matsunaga, N., & Ohdo, S. (2012). Stress-Regulated Transcription Factor ATF4 Promotes Neoplastic Transformation by Suppressing Expression of the INK4a/ARF Cell Senescence Factors. Cancer Research. https://doi.org/10.1158/0008-5472.can-11-1891
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.